Cyclosporine for Severe Drug Eruption in a Psoriasis Patient

Main Article Content

Sarina Singer
Nahla Shihab
Mark Lebwohl

Keywords

cyclosporine, psoriasis, drug eruption

Abstract

Abstract not available.

References

1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137:765.

2. Lerch M, Pichler WJ. The immunological and clinical spectrum of delayed drug induced exanthems. Curr Opin Allergy Clin Immunol 2004; 4:411.

3. Bircher AJ. Exanthematous (maculopapular) drug eruption. [Updated 2018 May 22]. In: UpToDate [Internet]. Available from: https://www.uptodate.com/contents/exanthematous-drug-eruption (accessed 11 November 2019).

4. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, et al. Guidelies of care for the management of psoriasis and psoriasis arthritis. J Am Acad Dermatol. 2011 Jul;65(1):137-74.

5. Mrowietz U, Domm S. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction. J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1022-5

6. Hardinger K, Magee CC. Pharmacology of cyclosporine and tacrolimus. [Updated 2018 April 25]. In: UpToDate [Internet]. Available from: https://www.uptodate.com/contents/pharmacology-of-cyclosporine-and-tacrolimus (accessed 11 November 2019).